Moses Rodriguez, MD - Publications

Neurology Mayo Clinic, Rochester, MN, United States 

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Watzlawik JO, Kahoud RJ, Wootla B, Painter MM, Warrington AE, Carey WA, Rodriguez M. Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study. Journal of Visualized Experiments : Jove. PMID 27404858 DOI: 10.3791/54139  0.4
2016 Mangalam AK, Rattan R, Suhail H, Singh J, Hoda MN, Deshpande M, Fulzele S, Denic A, Shridhar V, Kumar A, Viollet B, Rodriguez M, Giri S. AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis. Journal of Immunology (Baltimore, Md. : 1950). PMID 27354217 DOI: 10.4049/jimmunol.1501549  0.4
2016 Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports. 6: 28484. PMID 27346372 DOI: 10.1038/srep28484  0.4
2016 McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Lulu S, Ness J, Harris Y, Rubin J, ... ... Rodriguez M, et al. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Multiple Sclerosis and Related Disorders. 6: 87-92. PMID 27063630 DOI: 10.1016/j.msard.2016.02.011  0.4
2016 Wootla B, Watzlawik JO, Stavropoulos N, Wittenberg NJ, Dasari H, Abdelrahim MA, Henley JR, Oh SH, Warrington AE, Rodriguez M. Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opinion On Biological Therapy. PMID 26914737 DOI: 10.1517/14712598.2016.1158809  0.4
2015 Painter MM, Morrison JH, Zoecklein LJ, Rinkoski TA, Watzlawik JO, Papke LM, Warrington AE, Bieber AJ, Matchett WE, Turkowski KL, Poeschla EM, Rodriguez M. Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity. Plos Pathogens. 11: e1005311. PMID 26633895 DOI: 10.1371/journal.ppat.1005311  0.4
2015 Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A, Kumar A, Cerghet M, Elias S, Mohney RP, Rodriguez M, Rattan R, Mangalam AK, et al. Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. The Journal of Biological Chemistry. PMID 26546682 DOI: 10.1074/jbc.M115.679068  0.4
2015 Wootla B, Denic A, Watzlawik JO, Warrington AE, Rodriguez M. Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease. Molecular Neurobiology. PMID 26409478 DOI: 10.1007/s12035-015-9436-3  0.4
2015 Wootla B, Watzlawik JO, Warrington AE, Wittenberg NJ, Denic A, Xu X, Jordan LR, Papke LM, Zoecklein LJ, Pierce ML, Oh SH, Kantarci OH, Rodriguez M. Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases. Jama Neurology. PMID 26389734 DOI: 10.1001/jamaneurol.2015.2188  0.4
2015 Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, et al. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology. 85: 722-9. PMID 26208962 DOI: 10.1212/WNL.0000000000001856  0.4
2015 Xu X, Denic A, Jordan LR, Wittenberg NJ, Warrington AE, Wootla B, Papke LM, Zoecklein LJ, Yoo D, Shaver J, Oh SH, Pease LR, Rodriguez M. A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis. Disease Models & Mechanisms. PMID 26035393 DOI: 10.1242/dmm.020727  0.4
2015 Watzlawik JO, Kahoud RJ, O'Toole RJ, White KA, Ogden AR, Painter MM, Wootla B, Papke LM, Denic A, Weimer JM, Carey WA, Rodriguez M. Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal mice. Plos One. 10: e0128007. PMID 26020269 DOI: 10.1371/journal.pone.0128007  0.4
2015 Wootla B, Denic A, Watzlawik JO, Warrington AE, Rodriguez M. A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis. Journal of Neuroinflammation. 12: 83. PMID 25924771 DOI: 10.1186/s12974-015-0303-y  0.4
2015 Watzlawik JO, Kahoud RJ, Ng S, Painter MM, Papke LM, Zoecklein L, Wootla B, Warrington AE, Carey WA, Rodriguez M. Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders. Journal of Neurochemistry. PMID 25866077 DOI: 10.1111/jnc.13121  0.4
2015 Xu X, Ng SM, Hassouna E, Warrington A, Oh SH, Rodriguez M. Human-derived natural antibodies: biomarkers and potential therapeutics. Future Neurology. 10: 25-39. PMID 25678860 DOI: 10.2217/fnl.14.62  0.4
2015 Perschbacher K, Smestad JA, Peters JP, Standiford MM, Denic A, Wootla B, Warrington AE, Rodriguez M, Maher LJ. Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice. Nucleic Acid Therapeutics. 25: 11-9. PMID 25536292 DOI: 10.1089/nat.2014.0515  0.4
2015 Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH. Relapses and disability accumulation in progressive multiple sclerosis. Neurology. 84: 81-8. PMID 25398229 DOI: 10.1212/WNL.0000000000001094  0.4
2014 Mangalam AK, Luo N, Luckey D, Papke L, Hubbard A, Wussow A, Smart M, Giri S, Rodriguez M, David C. Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system. Journal of Immunology (Baltimore, Md. : 1950). 193: 4859-70. PMID 25339670 DOI: 10.4049/jimmunol.1302008  0.4
2014 Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, et al. Protective environmental factors for neuromyelitis optica. Neurology. 83: 1923-9. PMID 25339213 DOI: 10.1212/WNL.0000000000001001  0.4
2014 Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, et al. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. Journal of Child Neurology. PMID 25270659 DOI: 10.1177/0883073814550656  0.4
2014 Charvet LE, O'Donnell EH, Belman AL, Chitnis T, Ness JM, Parrish J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Krupp LB. Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1502-10. PMID 24687807 DOI: 10.1177/1352458514527862  0.4
2013 Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, et al. Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. Bmc Neurology. 13: 173. PMID 24225378 DOI: 10.1186/1471-2377-13-173  0.4
2013 Watzlawik JO, Wootla B, Painter MM, Warrington AE, Rodriguez M. Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire. Expert Review of Neurotherapeutics. 13: 1017-29. PMID 24053345 DOI: 10.1586/14737175.2013.835601  0.4
2013 Xu X, Wittenberg NJ, Jordan LR, Kumar S, Watzlawik JO, Warrington AE, Oh SH, Rodriguez M. A patterned recombinant human IgM guides neurite outgrowth of CNS neurons. Scientific Reports. 3: 2267. PMID 23881231 DOI: 10.1038/srep02267  0.4
2013 Wootla B, Watzlawik JO, Denic A, Rodriguez M. The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment. Expert Review of Clinical Immunology. 9: 535-49. PMID 23730884 DOI: 10.1586/eci.13.37  0.4
2013 Watzlawik JO, Warrington AE, Rodriguez M. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation. Plos One. 8: e55149. PMID 23383310 DOI: 10.1371/journal.pone.0055149  0.4
2013 Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 891-5. PMID 23232601 DOI: 10.1177/1352458512469693  0.4
2013 Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, ... ... Rodriguez M, et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. Journal of Child Neurology. 28: 102-7. PMID 23155206 DOI: 10.1177/0883073812464816  0.4
2013 Xu X, Denic A, Warrington AE, Bieber AJ, Rodriguez M. Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis. Journal of Clinical Immunology. 33: S50-6. PMID 22990667 DOI: 10.1007/s10875-012-9795-8  0.4
2013 Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 188-98. PMID 22736750 DOI: 10.1177/1352458512451510  0.4
2012 Warrington AE, Van Keulen V, Pease LR, Rodriguez M. Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG? Advances in Experimental Medicine and Biology. 750: 44-55. PMID 22903665 DOI: 10.1007/978-1-4614-3461-0_4  0.4
2012 Wittenberg NJ, Im H, Xu X, Wootla B, Watzlawik J, Warrington AE, Rodriguez M, Oh SH. High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance. Analytical Chemistry. 84: 6031-9. PMID 22762372 DOI: 10.1021/ac300819a  0.4
2012 Nastasijevic B, Wright BR, Smestad J, Warrington AE, Rodriguez M, Maher LJ. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. Plos One. 7: e39595. PMID 22761835 DOI: 10.1371/journal.pone.0039595  0.4
2012 Mangalam AK, Luckey D, Giri S, Smart M, Pease LR, Rodriguez M, David CS. Two discreet subsets of CD8 T cells modulate PLP 91-110 induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice Journal of Autoimmunity. 38: 344-353. PMID 22459490 DOI: 10.1016/j.jaut.2012.02.004  0.4
2012 Pavelko KD, Mendez-Fernandez Y, Bell MP, Hansen MJ, Johnson AJ, David CS, Rodriguez M, Pease LR. Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity. Plos Pathogens. 8: e1002541. PMID 22383876 DOI: 10.1371/journal.ppat.1002541  0.4
2012 Denic A, Pirko I, Wootla B, Bieber A, Macura S, Rodriguez M. Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis. Brain Pathology (Zurich, Switzerland). 22: 698-708. PMID 22335434 DOI: 10.1111/j.1750-3639.2012.00576.x  0.4
2011 Denic A, Macura SI, Warrington AE, Pirko I, Grossardt BR, Pease LR, Rodriguez M. A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination. Plos One. 6: e26001. PMID 22022490 DOI: 10.1371/journal.pone.0026001  0.4
2011 Wootla B, Denic A, Keegan BM, Winters JL, Astapenko D, Warrington AE, Bieber AJ, Rodriguez M. Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurology Research International. 2011: 780712. PMID 21961063 DOI: 10.1155/2011/780712  0.4
2011 Xu X, Warrington AE, Wright BR, Bieber AJ, Van Keulen V, Pease LR, Rodriguez M. A human IgM signals axon outgrowth: coupling lipid raft to microtubules. Journal of Neurochemistry. 119: 100-12. PMID 21824142 DOI: 10.1111/j.1471-4159.2011.07416.x  0.4
2011 Xu X, Warrington AE, Bieber AJ, Rodriguez M. Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network. Cns Drugs. 25: 555-73. PMID 21699269 DOI: 10.2165/11587830-000000000-00000  0.4
2011 Pavelko KD, Girtman MA, Mitsunaga Y, Mendez-Fernandez YV, Bell MP, Hansen MJ, Allen KS, Rodriguez M, Pease LR. Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy. Plos One. 6: e20217. PMID 21625449 DOI: 10.1371/journal.pone.0020217  0.4
2011 Wootla B, Lacroix-Desmazes S, Warrington AE, Bieber AJ, Kaveri SV, Rodriguez M. Autoantibodies with enzymatic properties in human autoimmune diseases. Journal of Autoimmunity. 37: 144-50. PMID 21624820 DOI: 10.1016/j.jaut.2011.05.007  0.4
2011 Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, Strober JB, Chabas D, Weinstock-Guttmann B, Ness J, Rodriguez M, Waubant E. Pediatric multiple sclerosis. Neurologic Clinics. 29: 481-505. PMID 21439455 DOI: 10.1016/j.ncl.2011.01.004  0.4
2011 Denic A, Zoecklein L, Kerkvliet J, Papke L, Edukulla R, Warrington A, Bieber A, Pease LR, David CS, Rodriguez M. Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosis. Brain Pathology (Zurich, Switzerland). 21: 501-15. PMID 21314744 DOI: 10.1111/j.1750-3639.2011.00474.x  0.4
2011 Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR, Weinstock-Guttman B. Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Archives of Neurology. 68: 437-44. PMID 21149803 DOI: 10.1001/archneurol.2010.325  0.4
2003 Zoecklein LJ, Pavelko KD, Gamez J, Papke L, McGavern DB, Ure DR, Njenga MK, Johnson AJ, Nakane S, Rodriguez M. Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus. Brain Pathology (Zurich, Switzerland). 13: 291-308. PMID 12946019  0.4
2002 Murray PD, McGavern DB, Pease LR, Rodriguez M. Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits. European Journal of Immunology. 32: 606-15. PMID 11857334 DOI: 10.1002/1521-4141(200203)32:3<606::AID-IMMU606>3.0.CO;2-D  0.4
1997 Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MB. Primary demyelination in transgenic mice expressing interferon-gamma. Nature Medicine. 3: 1037-41. PMID 9288735  0.4
Show low-probability matches.